Assistant Professor
Dana-Farber Cancer Institute
Boston, Massachusetts
Dr Elizabeth O’Donnell is the Director of Early Detection and Prevention at the Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School, Boston, USA. Dr O’Donnell is also an active investigator in a number of multiple myeloma trials and she specializes in plasma cell disorders with a particular interest in lifestyle medicine and patient and caregiver quality of life.
Disclosure information not submitted.
Piecing together the evidence: Optimizing anti-CD38 quads in transplant-eligible NDMM
Friday, September 19, 2025
11:30 - 12:00 East Coast USA Time